DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,132 filers reported holding DANAHER CORPORATION in Q1 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $298,071 | -10.6% | 1,193 | -10.6% | 0.01% | 0.0% |
Q1 2024 | $333,376 | +9.2% | 1,335 | +1.1% | 0.01% | 0.0% |
Q4 2023 | $305,369 | -6.8% | 1,320 | 0.0% | 0.01% | -16.7% |
Q3 2023 | $327,492 | +14.2% | 1,320 | +10.5% | 0.01% | +20.0% |
Q2 2023 | $286,800 | -4.9% | 1,195 | -0.1% | 0.01% | 0.0% |
Q1 2023 | $301,440 | +94991.5% | 1,196 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $317 | -99.9% | 1,196 | +2.1% | 0.01% | 0.0% |
Q3 2022 | $302,000 | -1.0% | 1,171 | -2.6% | 0.01% | 0.0% |
Q2 2022 | $305,000 | -13.6% | 1,202 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $353,000 | -10.6% | 1,202 | +0.2% | 0.01% | 0.0% |
Q4 2021 | $395,000 | +11.0% | 1,200 | +2.7% | 0.01% | 0.0% |
Q3 2021 | $356,000 | +6.3% | 1,169 | -6.3% | 0.01% | +25.0% |
Q2 2021 | $335,000 | -1.2% | 1,248 | -17.2% | 0.00% | 0.0% |
Q1 2021 | $339,000 | -2.3% | 1,507 | -3.6% | 0.00% | 0.0% |
Q4 2020 | $347,000 | +3.0% | 1,564 | 0.0% | 0.00% | -20.0% |
Q3 2020 | $337,000 | +26.2% | 1,564 | +3.5% | 0.01% | +25.0% |
Q2 2020 | $267,000 | +24.2% | 1,511 | -2.5% | 0.00% | 0.0% |
Q1 2020 | $215,000 | -11.9% | 1,550 | -2.7% | 0.00% | +33.3% |
Q4 2019 | $244,000 | +10.4% | 1,593 | +4.2% | 0.00% | 0.0% |
Q3 2019 | $221,000 | +1.4% | 1,529 | +0.2% | 0.00% | +50.0% |
Q2 2019 | $218,000 | -99.4% | 1,526 | -99.5% | 0.00% | -99.5% |
Q4 2018 | $34,168,000 | -2.7% | 331,341 | +2.5% | 0.42% | +25.6% |
Q3 2018 | $35,112,000 | +19.7% | 323,136 | +8.7% | 0.34% | +17.1% |
Q2 2018 | $29,330,000 | -13.4% | 297,224 | -14.1% | 0.29% | -11.7% |
Q1 2018 | $33,880,000 | -25.2% | 346,032 | -29.1% | 0.32% | -20.0% |
Q4 2017 | $45,323,000 | +14.3% | 488,293 | +5.6% | 0.41% | +10.0% |
Q3 2017 | $39,670,000 | +3.0% | 462,466 | +1.4% | 0.37% | 0.0% |
Q2 2017 | $38,497,000 | -15.6% | 456,185 | -14.5% | 0.37% | -15.6% |
Q1 2017 | $45,635,000 | -12.3% | 533,552 | -20.1% | 0.44% | -13.3% |
Q4 2016 | $52,008,000 | – | 668,139 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |